Lexicon Pharmaceuticals, Inc. (LXRX) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
2445 TECHNOLOGY FOREST BLVD. THE WOODLANDS, TX 77381 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 138,357 | 86,743 | 152,275 | 271,659 | 160,052 | 310,788 | |||
| Cash and cash equivalents | 46,345 | 64,065 | 126,263 | 36,112 | 80,386 | 61,661 | |||
| Short-term investments | 92,012 | 22,678 | 26,012 | 235,547 | 79,666 | 249,127 | |||
| Receivables | 28 | 14 | 395 | 56,532 | 5,924 | 4,825 | |||
| Inventory, net of allowances, customer advances and progress billings | 4,243 | 4,680 | 1,948 | ||||||
| Inventory | 4,243 | 4,680 | 1,948 | ||||||
| Other current assets | 2,481 | 2,164 | 5,049 | 5,320 | 2,668 | 4,434 | |||
| Total current assets: | 140,866 | 88,921 | 157,719 | 337,754 | 173,324 | 321,995 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | ✕ | ✕ | |||||||
| Property, plant and equipment | 2,071 | 1,176 | 295 | 14,047 | 15,865 | 17,687 | |||
| Intangible assets, net (including goodwill) | 44,543 | 44,543 | 44,543 | 64,259 | 94,662 | 96,428 | |||
| Goodwill | 44,543 | 44,543 | 44,543 | 44,543 | 44,543 | 44,543 | |||
| Intangible assets, net (excluding goodwill) | 19,716 | 50,119 | 51,885 | ||||||
| Other noncurrent assets | 6,819 | 2,269 | 1,231 | 1,655 | 285 | 429 | |||
| Total noncurrent assets: | 53,433 | 47,988 | 46,069 | 79,961 | 110,812 | 114,544 | |||
| TOTAL ASSETS: | 194,299 | 136,909 | 203,788 | 417,715 | 284,136 | 436,539 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 23,172 | 22,124 | 35,160 | 54,329 | 32,241 | 69,934 | |||
| Accounts payable | 10,395 | 9,152 | 5,469 | 12,178 | 17,759 | 57,652 | |||
| Accrued liabilities | 12,777 | 12,972 | 29,691 | 42,151 | 14,482 | 12,282 | |||
| Debt | 11,646 | 11,012 | 1,115 | 14,094 | |||||
| Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 40,099 | ||
| Other undisclosed current liabilities | 3,395 | ||||||||
| Total current liabilities: | 23,172 | 22,124 | 46,806 | 65,341 | 36,751 | 124,127 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation, including: | 5,424 | 1,102 | 243,887 | 231,576 | |||||
| Long-term debt, excluding current maturities | 234,171 | 243,887 | 231,576 | ||||||
| Other undisclosed long-term debt and lease obligation | 5,424 | (233,069) | |||||||
| Liabilities, other than long-term debt | 5,424 | 1,190 | 611 | 1,102 | 6,252 | 28,734 | |||
| Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 22,428 | ||
| Deferred tax liabilities, net | ✕ | ✕ | ✕ | ✕ | ✕ | 6,014 | 6,014 | ||
| Other liabilities | 5,424 | 1,190 | 611 | 1,102 | 238 | 292 | |||
| Operating lease, liability | ✕ | ✕ | |||||||
| Other undisclosed noncurrent liabilities | 43,155 | 233,069 | 23,651 | ||||||
| Total noncurrent liabilities: | 54,003 | 1,190 | 611 | 235,273 | 273,790 | 260,310 | |||
| Total liabilities: | 77,175 | 23,314 | 47,417 | 300,614 | 310,541 | 384,437 | |||
| Equity | |||||||||
| Equity, attributable to parent | 117,124 | 113,595 | 156,371 | 117,101 | (26,405) | 52,102 | |||
| Common stock | 189 | 150 | 142 | 106 | 106 | 106 | |||
| Treasury stock, value | (2,061) | (7,518) | (4,843) | (3,817) | (2,876) | (1,904) | |||
| Additional paid in capital | 1,709,144 | 1,608,749 | 1,561,096 | 1,462,172 | 1,447,954 | 1,435,526 | |||
| Accumulated other comprehensive income (loss) | (428) | (10) | (6) | 84 | (12) | (222) | |||
| Accumulated deficit | (1,589,720) | (1,487,776) | (1,400,018) | (1,341,444) | (1,471,577) | (1,381,404) | |||
| Total equity: | 117,124 | 113,595 | 156,371 | 117,101 | (26,405) | 52,102 | |||
| TOTAL LIABILITIES AND EQUITY: | 194,299 | 136,909 | 203,788 | 417,715 | 284,136 | 436,539 | |||
Income Statement (P&L) ($ in thousands)
| 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 139 | 298 | 23,995 | 322,073 | 63,209 | 90,335 | ||
| Revenue, net | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 90,335 | |
| Cost of revenue (Cost of Goods and Services Sold) | (1,929) | (3,231) | (2,491) | (1,899) | ||||
| Gross profit: | 139 | 298 | 22,066 | 318,842 | 60,718 | 88,436 | ||
| Operating expenses | (100,899) | (87,388) | (204,380) | (180,628) | (166,488) | (227,016) | ||
| Other undisclosed operating income | 134,514 | 3,231 | 2,491 | 1,899 | ||||
| Operating income (loss): | (100,760) | (87,090) | (47,800) | 141,445 | (103,279) | (136,681) | ||
| Nonoperating income (Other Nonoperating income) | 1,596 | 134 | 2,767 | 3,350 | 3,508 | 1,954 | ||
| Interest and debt expense | (2,780) | (802) | (13,541) | (20,676) | (20,777) | (6,984) | ||
| Income (loss) from continuing operations before income taxes: | (101,944) | (87,758) | (58,574) | 124,119 | (120,548) | (141,711) | ||
| Income tax benefit | 269 | 5,569 | 12,661 | |||||
| Income (loss) from continuing operations: | (101,944) | (87,758) | (58,305) | 129,688 | (120,548) | (129,050) | ||
| Income (loss) before gain (loss) on sale of properties: | ✕ | ✕ | (87,758) | (70,505) | 129,688 | (120,548) | (129,050) | |
| Loss from discontinued operations | (12,200) | |||||||
| Other undisclosed net income | 11,931 | 445 | ||||||
| Net income (loss): | (101,944) | (87,758) | (58,574) | 130,133 | (120,548) | (129,050) | ||
| Other undisclosed net loss attributable to parent | ||||||||
| Net income (loss) available to common stockholders, basic: | (101,944) | (87,758) | (58,574) | 130,133 | (120,548) | (129,050) | ||
| Dilutive securities, effect on basic earnings per share | (87,758) | (58,574) | 135,200 | |||||
| Net income (loss) available to common stockholders, diluted: | (101,944) | (175,516) | (117,148) | 265,333 | (120,548) | (129,050) | ||
Comprehensive Income ($ in thousands)
| 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (101,944) | (87,758) | (58,574) | 130,133 | (120,548) | (129,050) | ||
| Comprehensive income (loss): | (101,944) | (87,758) | (58,574) | 130,133 | (120,548) | (129,050) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (418) | (4) | (90) | 96 | 210 | (27) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (102,362) | (87,762) | (58,664) | 130,229 | (120,338) | (129,077) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.